Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment A. H. M. de Vries SchultinkA. A. SuleimanA. D. R. Huitema Review Open access 26 February 2016 Pages: 645 - 653
Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis Xiaoyan ZhongDan LaiYilan Huang Review 01 February 2016 Pages: 655 - 663
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation Ivy SongSteve WellerStephen Piscitelli Clinical Trial Open access 22 February 2016 Pages: 665 - 670
Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation Fadiea Al-AieshyRickard E MalmströmMika Skeppholm Pharmacodynamics 11 April 2016 Pages: 671 - 679
CES1P1 variant −816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril Hao-Jie ZhuTaimour Y. LangaeeJohn S. Markowitz Pharmacogenetics 26 February 2016 Pages: 681 - 687
Effects of the Chinese herbal formula “Zuojin Pill” on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype Furong QiuSongcan LiuJian Jiang Pharmacogenetics 29 March 2016 Pages: 689 - 695
The pharmacokinetics of vancomycin in patients with severe acute pancreatitis Juan HeEn-Qiang MaoEr-Zhen Chen Pharmacokinetics and Disposition 23 February 2016 Pages: 697 - 702
Significant effect of age on docetaxel pharmacokinetics in Japanese female breast cancer patients by using the population modeling approach Haruka OnoueIkuko YanoKazuo Matsubara Pharmacokinetics and Disposition 23 February 2016 Pages: 703 - 710
Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer’s disease A CoinM V PamioR Padrini Pharmacokinetics and Disposition 08 March 2016 Pages: 711 - 717
A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib Ferdows AtiqAnnoek E C BroersJorie Versmissen Pharmacokinetics and Disposition Open access 11 March 2016 Pages: 719 - 723
The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers S. El MessaoudiF. G. RusselN. P. Riksen Pharmacokinetics and Disposition Open access 15 March 2016 Pages: 725 - 730
Drug-related mortality among inpatients: a retrospective observational study Alfredo José Pardo CabelloEsperanza Del Pozo GavilánEmilio Puche Cañas Pharmacoepidemiology and Prescription 20 February 2016 Pages: 731 - 736
Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field Johann Castañeda-SanabriaDavid HajageFlorence Tubach Pharmacoepidemiology and Prescription 26 February 2016 Pages: 737 - 746
Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden Pia FriskSofia K SporrongMia von Euler Pharmacoepidemiology and Prescription 27 February 2016 Pages: 747 - 754
Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate use Xavier VidalAntonia Agustíon behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project Pharmacoepidemiology and Prescription 05 March 2016 Pages: 755 - 764
Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia Svetla GadzhanovaElizabeth E. RougheadLouise E. Bartlett Pharmacoepidemiology and Prescription 10 March 2016 Pages: 765 - 771
Limited sampling strategies for once daily tacrolimus exposure monitoring Antonio J. Carcas-Sansuán Letter to the Editors 03 March 2016 Pages: 773 - 774
Response: Limited sampling strategies for once daily tacrolimus exposure monitoring D. J. A. R MoesJ. J. SwenB. van Hoek Letter to the Editors 02 March 2016 Pages: 775 - 776
